| P50 | author | Zhiwei Chen | Q59683851 |
| | L Liu | Q73365179 |
| P2093 | author name string | Hui Wang | |
| | Chuan Qin | |
| | Qiang Wei | |
| | Patricia Molina | |
| | Zhe Cong | |
| | Xiaoxian Wu | |
| P2860 | cites work | Impact of simian immunodeficiency virus (SIV) infection on lymphocyte numbers and T-cell turnover in different organs of rhesus monkeys | Q44400573 |
| | Medical marijuana: tribulations and trials. | Q45947982 |
| | Tetrahydrocannabinol suppresses immune function and enhances HIV replication in the huPBL-SCID mouse | Q46553874 |
| | Cannabinoid receptors and their endogenous agonists | Q48464429 |
| | A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men | Q58370813 |
| | Elevation of IgE in HIV-infected subjects: a marker of poor prognosis | Q67513131 |
| | Cannabinoids enhance human B-cell growth at low nanomolar concentrations | Q71706855 |
| | Modulation of HIVGP120 Antigen-Specific Immune Responses In Vivo by Δ9-Tetrahydrocannabinol | Q87163708 |
| | The therapeutic potential of cannabis and cannabinoids | Q24600806 |
| | Minireview: From the bench, toward the clinic: therapeutic opportunities for cannabinoid receptor modulation | Q26829111 |
| | The effects of cannabinoids on the brain | Q28137626 |
| | Mechanisms of IgE elevation in HIV-1 infection | Q28200843 |
| | Δ(9)-Tetrahydrocannabinol treatment during human monocyte differentiation reduces macrophage susceptibility to HIV-1 infection | Q33605261 |
| | Modulation of gut-specific mechanisms by chronic δ(9)-tetrahydrocannabinol administration in male rhesus macaques infected with simian immunodeficiency virus: a systems biology analysis | Q33713868 |
| | Enhanced infectivity of an R5-tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pig-tailed macaques (Macaca nemestrina). | Q33807885 |
| | Therapeutic potential of cannabinoids in CNS disease | Q33964721 |
| | Pharmacology of cannabinoid CB1 and CB2 receptors. | Q34442847 |
| | Chronic Δ⁹-tetrahydrocannabinol administration may not attenuate simian immunodeficiency virus disease progression in female rhesus macaques | Q34606565 |
| | Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep | Q34641364 |
| | Repressive effect of primary virus replication on superinfection correlated with gut-derived central memory CD4(+) T cells in SHIV-infected Chinese rhesus macaques | Q34983902 |
| | Effects of smoked marijuana in healthy and HIV + marijuana smokers | Q34986730 |
| | Chronic administration of Δ9-tetrahydrocannabinol induces intestinal anti-inflammatory microRNA expression during acute simian immunodeficiency virus infection of rhesus macaques | Q34991150 |
| | Immunoregulation of a CB2 receptor agonist in a murine model of neuroAIDS | Q35028750 |
| | Cannabinoid Administration Attenuates the Progression of Simian Immunodeficiency Virus | Q35092384 |
| | Cannabinoid neuroimmune modulation of SIV disease | Q35529056 |
| | Effects of Cannabinoids on T-cell Function and Resistance to Infection | Q35752185 |
| | Cannabinoid 2 (CB2) receptor involvement in the down-regulation but not up-regulation of serum IgE levels in immunized mice | Q36166294 |
| | Histamine increases the level of IFNγ produced by HIV-1 specific CTLs and this production depends on total IgE level | Q37950820 |
| | The role of CB1 in immune modulation by cannabinoids | Q38069344 |
| | Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation | Q38087533 |
| | CD4+ lymphocytopenia in acute infection of Asian macaques by a vaginally transmissible subtype-C, CCR5-tropic Simian/Human Immunodeficiency Virus (SHIV). | Q38942811 |
| | Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium | Q39077826 |
| | SIV(mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans | Q39182178 |
| | Acute infection of Chinese macaques by a CCR5-tropic SHIV carrying a primary HIV-1 subtype B' envelope. | Q39573659 |
| | Delta9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells | Q40987444 |
| | IgE-bearing cells and epsilon-specific mRNA in lymphoid organs of two children with AIDS. | Q44164805 |
| | Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients | Q44202500 |
| P433 | issue | 3 | |
| P921 | main subject | tetrahydrocannabinol | Q190067 |
| | cannabinoids | Q422936 |
| P304 | page(s) | 584-591 | |
| P577 | publication date | 2016-04-25 | |
| P1433 | published in | Journal of Neuroimmune Pharmacology | Q6295645 |
| P1476 | title | Chronic Δ(9)-Tetrahydrocannabinol Administration Reduces IgE(+)B Cells but Unlikely Enhances Pathogenic SIVmac251 Infection in Male Rhesus Macaques of Chinese Origin | |
| P478 | volume | 11 | |